Team & Investors

Leadership, board of directors, and investment partners

Executives
0
Board Members
0
Investors
15
Total Funding
$38.6M
Investors
15 investors across all rounds
AH
AlphaLab Health
BA
BlueTree Allied Angels
BH
Boston Harbor Angels
CN
Carl Nicolia
DC
Delaware Crossing Investor Group

+10 more investors

Sign in to view all

CytoAgents Leadership & Investors

CytoAgents is led by a team of experienced leaders. The company has attracted investment from 15 institutional and strategic investors.

Who Has Invested in CytoAgents?

CytoAgents has raised $38.6M from 15 investors including venture capital firms, private equity investors, and strategic partners.

Investment Opportunity

Accredited investors can access CytoAgents shares through secondary market platforms like Premier Alternatives, joining the company's existing institutional investor base.